Seborrheic dermatitis (SD) is a common chronic inflammatory skin disorder affecting the scalp, face, eyebrows, ears, chest, and other oil-rich areas. The condition causes:

• Persistent dandruff
• White or yellow scales
• Red, irritated patches
• Itching or burning
• Flare-ups triggered by stress, weather, or immune imbalance

Although SD is not dangerous, it can significantly impact quality of life and self-confidence.

The exact cause is multifactorial, involving:

• Malassezia yeast (fungal overgrowth)
• Excess sebum production
• Immune overreaction
• Skin barrier dysfunction
• Environmental triggers
• Genetic predisposition

Seborrheic dermatitis is associated with increased inflammation and can worsen in individuals with stress, fatigue, neurological conditions, or hormone changes.

Why Conventional Treatments Often Fall Short

Standard medical treatments include:

• Ketoconazole or ciclopirox antifungal shampoo
• Hydrocortisone or topical steroids
• Calcineurin inhibitors (pimecrolimus, tacrolimus)
• Zinc pyrithione or selenium sulfide shampoos
• Barrier-repair moisturizers

These treatments help control symptoms—but SD tends to recur, because the underlying inflammation and immune response are not fully addressed.

This has led researchers to explore regenerative and immunomodulatory approaches, including Mesenchymal Stem Cell (MSC) therapy.

How Inflammation and Immune Imbalance Drive Seborrheic Dermatitis

Multiple studies confirm that SD is not merely a fungal issue—it is an inflammatory skin disorder.

Biological factors include:

• Overactivation of T cells
• Elevated inflammatory cytokines (IL-6, IL-8, TNF-α)
• Altered immune response to Malassezia yeast
• Oxidative stress in sebaceous glands
• Impaired skin barrier proteins (e.g., filaggrin)

UC-MSCs are known for modulating the immune response and supporting skin barrier repair, which is why they are being studied as adjunctive therapy.

The Role of UC-MSC Stem Cell Therapy in Seborrheic Dermatitis

While stem cells are not a first-line or primary treatment for seborrheic dermatitis, their anti-inflammatory and skin-repairing properties may provide supportive benefits in difficult or chronic cases.

At EDNA Wellness, UC-MSCs used are sourced from TISTR/วว GMP-certified laboratories, ensuring high-quality, sterile, and biologically active cells.

How UC-MSCs may support SD management

1. Immunomodulation

MSCs reduce pro-inflammatory cytokines such as:

• TNF-α
• IL-6
• IL-1β

Chronic SD is heavily driven by immune overreaction, so calming the inflammatory environment may reduce flares.

2. Skin Barrier Repair

MSCs release growth factors that promote:

• Keratinocyte repair
• Collagen stimulation
• Improved epidermal barrier function

A stronger skin barrier reduces sensitivity to yeast and environmental triggers.

3. Anti-fungal Environment

Some studies show MSC secretome reduces inflammatory response to Malassezia by regulating TLR2 pathways.

4. Reduction of oxidative stress

UC-MSCs help neutralize ROS (free radicals), which are elevated in SD lesions.

5. Healing of chronic redness and irritation

Through angiogenic and anti-inflammatory pathways, MSCs may reduce erythema and improve overall skin health.

How MSC therapy is used in dermatology

Globally, MSCs are being studied for:

• Eczema
• Psoriasis
• Atopic dermatitis
• Rosacea
• Acne scarring
• Skin barrier disorders

Seborrheic dermatitis shares similar inflammatory patterns with these conditions.

What Results Can Patients Expect?

Stem cell therapy is not a cure, but many patients may experience:

• Reduced intensity of flare-ups
• Improved skin tolerance
• Less redness and irritation
• Better skin barrier strength
• Reduction in chronic inflammation
• More stable long-term control of symptoms

Improvements typically appear gradually over 4–12 weeks as inflammation decreases and skin structure strengthens.

When to Consider Stem Cell Therapy for Seborrheic Dermatitis

You may be a candidate if:

• Your SD is chronic or severe
• You experience frequent flare-ups
• Topical medications help only temporarily
• Your skin is sensitive to steroid creams
• You prefer long-term inflammation control rather than repeated medications
• You have associated immune dysregulation or neurological conditions

UC-MSC therapy is most useful for patients seeking a holistic, cellular approach to controlling chronic inflammatory skin disease.

Seborrheic dermatitis is a chronic inflammatory condition that requires more than just antifungal shampoos. UC-MSC stem cell therapy, especially when sourced from GMP-certified labs, offers promising adjunctive benefits by calming inflammation, restoring the skin barrier, and improving long-term stability.

About EDNA Wellness

EDNA Wellness is a private clinic specializing in Stem Cell Therapy in Bangkok, Thailand for Neurology & Stroke as well as Bones & Joints. Beyond rehabilitation, we also provide aesthetic and wellness treatments to support your full-body vitality. All delivered with expert care and compassion

For more information or inquiries, contact us via

LINE @ednawellness

WhatsApp +66 (0) 64 505 5599

www.ednawellness.com

References

• Arora, P., Sharma, S., & Bansal, S. (2021). Seborrheic dermatitis: Etiology, clinical presentation, and therapeutic options. Journal of Clinical and Aesthetic Dermatology, 14(6), 32–44.
• Kim, J., et al. (2021). Mesenchymal stem cell secretome and skin inflammation: A review. Journal of Dermatological Science, 104(2), 69–79.
• Chen, L., et al. (2020). MSC therapy for inflammatory skin disorders. Stem Cell Research & Therapy, 11, 1–12.
• Jin, S. H., et al. (2018). Toll-like receptor pathways in seborrheic dermatitis. Experimental Dermatology, 27(3), 265–270.
• Park, H. J., et al. (2020). The effect of MSC-derived exosomes in dermatology. International Journal of Molecular Sciences, 21(23), 9024.